sign in
<Profile> by @dansshadow.bsky.social▾
uri: at://mbarber.bsky.social/app.bsky.actor.profile/self
loading...
Loading...
Health economics, law, global health, and access to medicines. Economist @ MSF-USA but views my own. https://melissajbarber.github.io.
Melissa Barber

Loading...
I've walked thru the economic logic here, but Gilead obviously does not say this out loud. They don't really have a good reason not to sell to MSF, which is why they landed on negotiating supply contracts is "a lot of work" (actual thing they said). 13/ www.doctorswithoutborders.org/latest/preve...
Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization.. statnews.com/pharmalot/20... #pharma #HIV #AIDS #pharma #Gilead
11h
16h
The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.
Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization
statnews.com
www.doctorswithoutborders.org
MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.
Open letter to Gilead: Prevention should not be a privilege
Melissa Barber